Q32 Bio (QTTB)
NASDAQ:QTTB
Holding QTTB?
Track your performance easily

Q32 Bio (QTTB) Stock News & Sentiment

740 Followers
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
Premium
Company Announcements
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
2M ago
Q32 Bio (QTTB) has issued an announcement. Q32 Bio Inc. has successfully completed the enrollment phase for the SIGNAL-AD Phase 2 clinical trial of their drug bempikibart, aimed at treating ...Read more
Q32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
Premium
Company Announcements
Q32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
4M ago
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
4M ago

News Score - Last 7 Days

Neutral
QTTB
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is QTTB’s Media Buzz Sentiment?
1 articles about QTTB were published this week. In an average week, 1 articles are published.
    What is QTTB’s weekly average amount of articles?
    In an average week, 1 articles about QTTB are published.
      What is QTTB’s News Sentiment?
      50% of articles about QTTB were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        COOCooper Co
        VEEVVeeva Systems
        PSQPacific Smiles Group Ltd
        JUMPLeveljump Healthcare Corp.
        ELMDElectromed
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis